大连百傲化学股份有限公司 关于收到大连证监局行政监管措施决定书的公告

Core Points - The company received an administrative regulatory measure from the Dalian Bureau of the China Securities Regulatory Commission on August 14, 2025, due to internal control deficiencies [1][2] - The identified issues include problems in fund management, procurement management, and contract management within the company and its wholly-owned subsidiary, Shenyang Bai'ao Chemical Co., Ltd. [1][2] - The chairman Liu Xianwu and the financial director Wang Xiliang are held primarily responsible for these violations of the Corporate Governance Code and internal control guidelines [2] Regulatory Actions - The company is required to take corrective actions and submit a written report within 30 days of receiving the decision [2][3] - Liu Xianwu and Wang Xiliang will receive warning letters, which will be recorded in the securities market integrity archives [2] - The company emphasizes that these regulatory measures will not affect its normal production and management activities [3] Company Response - The company acknowledges the issues and commits to actively rectify them while enhancing internal management and compliance with securities laws [3] - The board of directors, supervisors, and senior management will strengthen their understanding of relevant regulations to improve operational standards [3]